-
Mashup Score: 0SGO Leadership, Engagement, and Action in Diversity (LEAD) Program | Society of Gynecologic Oncology - 10 month(s) ago
The Leadership, Engagement, and Action in Diversity (LEAD) Program is a six-month mentored pipeline opportunity created by the SGO Committee on Diversity, Inclusion and Health Equity (DIHE). The LEAD program offers Underrepresented in Medicine (URiM) trainees sponsorship, resources, and aRead More ›
Source: www.sgo.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Study of Elite College Admissions Data Suggests Being Very Rich Is Its Own Qualification - 10 month(s) ago
Extraordinarily detailed data shows how elite colleges prefer the richest students, even among students with similar test scores.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Mary "Dicey" Scroggins Travel FundRequest for Applications - GOG - 1 year(s) ago
Mary “Dicey” Jackson Scroggins, a long-time patient advocate and mentor, passed away on August 1, 2022. Dicey was a 26-year […]
Source: GOGCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 11HPV-independent and HPV-associated vulvar squamous cell carcinoma: two different cancers - 2 year(s) ago
Objectives We report the disease-specific survival of patients with human papillomavirus (HPV)-associated and HPV-independent vulvar squamous cell carcinomas and determine whether differences exist and are independent of stage and age at diagnosis. Methods This was a retrospective cohort study with case note and pathology slide review of 265 consecutive women with vulvar squamous cell carcinoma….
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned coprimary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
This Viewpoint evaluates factors introduced by the overturn of Roe v Wade that will further complicate the complex, multidisciplinary decision-making involved in treating patients with pregnancy-associated cancer.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3
One of two Indigenous students in his Harvard Medical School class reflects on the lack of representation of Native peoples in medicine and why it matters.
Source: BostonGlobe.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5
I have been waiting to talk about this topic for a while and the time is now. There is a lot of nonsense that gets said to early-career faculty, especially women of color, in academic medicine and public health in the guise of ‘advice’. Lots of it…
Source: BuzzsproutCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Uterine Cancer Is on the Rise, Especially Among Black Women - 2 year(s) ago
The cancer eventually will become the third most common type among women, experts say. The mortality rate is highest among Black Americans.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
This survey study examines changes in breast, cervical, and colorectal cancer screening prevalence during the COVID-19 pandemic in the US.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
https://t.co/fyIdz5oC76